在COVID-19大流行期间青少年糖尿病自我管理方案和结果:一个范围审查
Jason Nguyen1, William Le1, Roberta Brugger1
1Diabetes and Endocrinology, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Tampa, USA.
Cureus
|January 27, 2025
概括
随着COVID-19的流行,患有糖尿病的青少年面临了挑战. 虽然有些人通过持续血糖监测 (CGM) 和远程医疗改善了血糖控制,但许多人面临体重增加和压力,这影响了他们的健康状况.
科学领域:
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
- 青少年医学 青少年医学
背景情况:
- 患有糖尿病 (DM) 的青少年通常具有较差的血糖控制和自我管理的坚持.
- COVID-19大流行给青少年的DM自我管理带来了重大挑战,包括社交距离和增加的压力因素.
研究的目的:
- 在COVID-19大流行期间检查1型和2型DM的青少年 (10-17岁) 的自我管理方案和结果.
- 综合关于血糖控制,生活方式行为,医疗保健利用和心理社会福祉的发现.
主要方法:
- 根据PRISMA-ScR指南进行了范围审查.
- 搜索了三个在线数据库,并选了同行评审的文章 (n=32).
- 使用乔安娜·布里格斯研究所 (JBI) 批判性评估检查清单评估偏见,并按主题分类发现.
主要成果:
- 使用持续血糖监测 (CGM),调整胰岛素和使用远程医疗的青少年经常保持或改善血糖控制.
- 许多青少年体重增加,体力活动减少,饮食/睡眠习惯差,压力增加,对血糖控制产生负面影响.
- 远程医疗的使用是广泛的,并得到了积极的接待;急性并发症的发生率各不相同.
结论:
- 患有DM的青少年在COVID-19大流行期间面临着多方面的挑战,影响身体,行为和心理社会方面.
- 需要进一步研究长期影响;多层次干预对于改善公共卫生紧急情况期间的DM自我管理至关重要.
- 干预措施应侧重于促进CMG,体育活动,健康饮食和减少DM青少年的压力.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

